Please use this identifier to cite or link to this item:
|Title:||Metabotyping of docosahexaenoic acid - Treated alzheimer's disease cell model||Authors:||Bahety, P.
|Issue Date:||27-Feb-2014||Citation:||Bahety, P., Tan, Y.M., Hong, Y., Zhang, L., Chan, E.C.Y., Ee, P.-L.R. (2014-02-27). Metabotyping of docosahexaenoic acid - Treated alzheimer's disease cell model. PLoS ONE 9 (2) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0090123||Abstract:||Background: Despite the significant amount of work being carried out to investigate the therapeutic potential of docosahexaenoic acid (DHA) in Alzheimer's disease (AD), the mechanism by which DHA affects amyloid-β precursor protein (AβPP)-induced metabolic changes has not been studied. Objective: To elucidate the metabolic phenotypes (metabotypes) associated with DHA therapy via metabonomic profiling of an AD cell model using gas chromatography time-of-flight mass spectrometry (GC/TOFMS). Methods: The lysate and supernatant samples of CHO-wt and CHO-AβPP695 cells treated with DHA and vehicle control were collected and prepared for GC/TOFMS metabonomics profiling. The metabolic profiles were analyzed by multivariate data analysis techniques using SIMCA-P+ software. Results: Both principal component analysis and subsequent partial least squares discriminant analysis revealed distinct metabolites associated with the DHA-treated and control groups. A list of statistically significant marker metabolites that characterized the metabotypes associated with DHA treatment was further identified. Increased levels of succinic acid, citric acid, malic acid and glycine and decreased levels of zymosterol, cholestadiene and arachidonic acid correlated with DHA treatment effect. DHA levels were also found to be increased upon treatment. Conclusion: Our study shows that DHA plays a role in mitigating AbPP-induced impairment in energy metabolism and inflammation by acting on tricarboxylic acid cycle, cholesterol biosynthesis pathway and fatty acid metabolism. The perturbations of these metabolic pathways by DHA in CHO-wt and CHO-AβPP695 cells shed further mechanistic insights on its neuroprotective actions. © 2014 Bahety et al.||Source Title:||PLoS ONE||URI:||http://scholarbank.nus.edu.sg/handle/10635/106139||ISSN:||19326203||DOI:||10.1371/journal.pone.0090123|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
|2014_Metabotyping_of_docosahexaenoic_acid-published.PDF||819.4 kB||Adobe PDF|
checked on Aug 14, 2019
WEB OF SCIENCETM
checked on Aug 7, 2019
checked on Aug 16, 2019
checked on Aug 16, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.